Pure Financial Advisors LLC increased its position in Lam Research Corporation (NASDAQ:LRCX – Free Report) by 77.3% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,874 shares of the semiconductor company’s stock after acquiring an additional 6,919 shares during the quarter. Pure Financial Advisors LLC’s holdings in Lam Research were worth $6,879,000 at the end of the most recent quarter.
Several other hedge funds also recently bought and sold shares of the company. Bayban purchased a new stake in Lam Research in the 4th quarter worth approximately $26,000. Vermillion Wealth Management Inc. purchased a new position in shares of Lam Research during the 1st quarter valued at $26,000. Cedar Mountain Advisors LLC increased its holdings in shares of Lam Research by 242.9% in the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock worth $26,000 after purchasing an additional 85 shares during the period. Paladin Partners LLC purchased a new stake in shares of Lam Research in the second quarter worth $26,000. Finally, Mcguire Capital Advisors Inc. purchased a new stake in shares of Lam Research in the fourth quarter worth $27,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.
Lam Research Stock Down 0.6%
Shares of LRCX opened at $312.88 on Thursday. The firm has a market cap of $391.51 billion, a P/E ratio of 54.32, a P/E/G ratio of 1.25 and a beta of 1.84. The stock has a 50 day simple moving average of $333.58 and a two-hundred day simple moving average of $288.43. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91. Lam Research Corporation has a 1 year low of $94.11 and a 1 year high of $438.50.
Key Headlines Impacting Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: AI-focused R&D expansion: Lam Research broke ground on a 120,000-square-foot laboratory in Tualatin, Oregon, as part of a planned investment of more than $3 billion in its global lab network over the next five years. The facility is intended to support collaboration with chipmakers and accelerate equipment innovations for advanced AI semiconductors. Lam Research Oregon lab announcement
- Positive Sentiment: Strong AI demand outlook: CEO Tim Archer said increasingly complex AI models require more computing power, bandwidth and storage, creating demand for semiconductor innovation. The investment reinforces Lam’s positioning as a supplier to the AI infrastructure buildout. Lam Research AI investment video
- Positive Sentiment: Favorable analyst and fundamentals commentary: Zacks highlighted AI-driven growth, recurring services revenue, earnings momentum and Lam’s balance sheet, while Mizuho maintained an “outperform” rating despite trimming its price target to $365 from $370. Lam’s latest reported quarter also showed 30% year-over-year revenue growth and an earnings beat.
- Neutral Sentiment: Investor outreach scheduled: CFO Doug Bettinger will participate in upcoming investor conferences. The events could provide updates on demand, AI exposure and the Oregon investment, but no new financial guidance was announced. Lam Research conference announcement
- Negative Sentiment: Investment and valuation concerns: The multibillion-dollar R&D expansion will raise near-term capital and operating costs, while the stock’s high earnings multiple leaves less room for disappointment. The modest analyst price-target reduction may also have limited enthusiasm.
Analyst Upgrades and Downgrades
Several equities analysts recently commented on the company. TD Cowen restated a “buy” rating and set a $400.00 target price (up from $340.00) on shares of Lam Research in a research report on Thursday, July 9th. Oppenheimer reaffirmed an “outperform” rating and issued a $400.00 target price (up from $330.00) on shares of Lam Research in a research note on Monday, June 15th. Seaport Research Partners initiated coverage on shares of Lam Research in a research report on Monday, May 4th. They set a “buy” rating and a $300.00 target price for the company. HSBC reissued a “hold” rating and issued a $333.00 price target on shares of Lam Research in a research note on Monday, July 27th. Finally, Sanford C. Bernstein raised their price objective on shares of Lam Research from $325.00 to $340.00 and gave the company an “outperform” rating in a research report on Thursday, May 21st. One analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, Lam Research presently has a consensus rating of “Moderate Buy” and a consensus price target of $357.31.
Read Our Latest Research Report on Lam Research
Insiders Place Their Bets
In other news, Director Eric Brandt sold 54,500 shares of Lam Research stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the transaction, the director owned 199,205 shares in the company, valued at approximately $69,881,114. The trade was a 21.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $309.60, for a total value of $2,371,226.40. Following the transaction, the senior vice president owned 58,470 shares in the company, valued at approximately $18,102,312. The trade was a 11.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 80,441 shares of company stock valued at $27,614,296 over the last three months. Insiders own 0.31% of the company’s stock.
About Lam Research
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Recommended Stories
- Five stocks we like better than Lam Research
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
